mfmainlogo

    Tata India Pharma & Healthcare Fund (IDCW) - Payout

    Tata India Pharma & Healthcare Fund (IDCW) - Payout is a Sectoral Fund mutual fund. The fund has delivered around 7.85% returns in the last 1 year and currently has a NAV of ₹ 32.14 as of 22 Sep 2026. Investors can start with a minimum SIP of ₹ 100.0.

    Tata India Pharma & Healthcare Fund (IDCW) - Payout

    Equity · Sectoral Fund

    Enter Amount
    ₹

    Monthly SIP
    Every Month calender

    By proceeding, you accept Bajaj Broking’s *T&C

    Invest Now

    Calculate Your Returns

    Select Duration

    Total Value : ₹5,434

    When you invest ₹100 over 3 years

    Returns%

    19.08% annually for last 3 years

    Invested Gains
    Other Information
    other info  Mobile other info
    Fund Age Icon

    Fund Age :

    10 years

    AUM Icon

    AUM :

    ₹1565.28 Cr.

    Lock-in Period Icon

    Lock-in Period :

    0

    Exit Load Icon

    Exit Load :

    0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment.

    Expense Ratio Icon

    Expense Ratio :

    2.32% (inclusive of GST)

    Tax Icon

    Tax Implication

    Withdrawal within 1 year:
    5% tax on gains

    Withdrawal after 1 year:
    10% tax on gains above 21 lakh per financial year

    Watch these short videos to learn more

    NAV Icon
    NAV Icon

    NAV

    Play
    Tax Icon
    Tax Icon

    Tax

    Play
    Exit Load Icon
    Exit Load Icon

    Exit Load

    Play
    Expense Ratio Icon
    Expense Ratio Icon

    Expense Ratio

    Play
    Lock-in Icon
    Lock-in Icon

    Lock-in

    Play
    Fund Manager
    collapse-icon mobile-collapse-icon
    MS
    Meeta Shetty
    From Mar 2017 till date with Tata Asset Management Pvt Ltd reporting to Chief Investment Officer - Equities. Earlier she was Research Analyst, tracking Pharma, Technology and Telecom sector. Reporting to the Chief Investment Officer - Equities. From Dec 2014 to Feb 2017 with Kotak Securities, tracking Pharma sector. Reporting to the Head of Research. From Jun 2013 to Nov 2014 with HDFC Securities, as Research Analyst, tracking Pharma sector. Reporting to Head of Research. From Sep 2011 to Jun 2013 with AMSEC (Asian Market Securities) as Research Analyst, tracking Pharma sector. Reporting to Head of Research. From May 2010 to Sep 2011 with Dalal & Broacha Stock Broking as Research Analyst, tracking Pharma sector. Reporting to Head of Research.
    RS
    Rajat Srivastava
    From 6thSeptember 2024 onwards With Tata Asset Management Private Limited as Assistant Fund Manager & Research Analyst having responsibilities for Healthcare & Chemicals sector coverage, reporting to Chief Investment Officer - Equities. From October2022 to September 2024 With Incred Asset Management as AVP Investments having responsibilities for Automobile, Healthcare & Diversified sectors reporting to Fund Manager and CEO/CIO. From April 2022 to October 2022 With Kotak Investment Banking as Assistant Vice President-Corporate Advisory having responsibilities for Deal sourcing and reporting to Managing Director-Corporate Advisory Group. From November202 0 to April202 2 With Incred Asset Management as AVP Investments having responsibilities as Healthcare Analyst reporting to Fund Manager. From September20 19 to November 2020 With Emkay Global as Research Associate having responsibilities for coverage of healthcare sector stocks reporting to Lead Analyst. From June 2019 to September 2019 With Evalueserve (Client - Deutsche Securities) as Research Lead having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. From May 2016 to June20 19 With Motilal Oswal Financial Services as Assistant manager - Research having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. o
    Risk & Rating
    risk rating  risk-rating-icons
    chart
    value-research
    Value Research Rating
    Value Research
    0★
    Other Funds by Tata Mutual Fund
    other funds Mobile Other Funds Icons
    Funds Name
    1Y Returns
    expand-all-icon swap_horiz-icon

    Start your SIP with just ₹100

    Choose from 4,000+ funds on Bajaj Broking

    +91

    |

    Start your SIP with just ₹100

    Choose from 4,000+ funds on Bajaj Broking

    +91

    |

    Frequently Asked Questions

    How to Invest in Tata India Pharma & Healthcare Fund (IDCW) - Payout?

    To invest in Tata India Pharma & Healthcare Fund (IDCW) - Payout, visit Tata Mutual Fund or use a trusted platform like Bajaj Broking. Ensure your KYC is complete, select your preferred mode - SIP or Lump Sum — enter the amount, and proceed with the investment.

    What kind of returns does Tata India Pharma & Healthcare Fund (IDCW) - Payout offer?

    Tata India Pharma & Healthcare Fund (IDCW) - Payout has delivered approximately 7.85% over the last 1 year.

    How much expense ratio is charged by Tata India Pharma & Healthcare Fund (IDCW) - Payout?

    Tata India Pharma & Healthcare Fund (IDCW) - Payout charges an expense ratio 2.32%.

    What is the AUM of Tata India Pharma & Healthcare Fund (IDCW) - Payout?

    As of October 2026, Tata India Pharma & Healthcare Fund (IDCW) - Payout holds an AUM of ₹1,565.28 crore. This reflects the scale of investor participation in the fund and broadly indicates the level of investor interest it has earned over time.

    Can I invest in SIP and Lump Sum in Tata India Pharma & Healthcare Fund (IDCW) - Payout?

    Yes, Tata India Pharma & Healthcare Fund (IDCW) - Payout supports both SIP and Lump Sum investment modes. The minimum SIP amount starts at ₹100.0, while Lump Sum investments require a minimum of ₹5,000.0. Investors may choose either mode based on their financial planning preference.

    What is the NAV of Tata India Pharma & Healthcare Fund (IDCW) - Payout?

    The NAV of Tata India Pharma & Healthcare Fund (IDCW) - Payout stands at ₹32.14 as of 22 Sep 2026. Updated at the close of every trading day, the NAV serves as an accurate measure of the fund's per-unit value at any given point.

    Who manages Tata India Pharma & Healthcare Fund (IDCW) - Payout?

    Tata India Pharma & Healthcare Fund (IDCW) - Payout is managed by the following fund manager(s):

    • Meeta Shetty

      From Mar 2017 till date with Tata Asset Management Pvt Ltd reporting to Chief Investment Officer - Equities. Earlier she was Research Analyst, tracking Pharma, Technology and Telecom sector. Reporting to the Chief Investment Officer - Equities. From Dec 2014 to Feb 2017 with Kotak Securities, tracking Pharma sector. Reporting to the Head of Research. From Jun 2013 to Nov 2014 with HDFC Securities, as Research Analyst, tracking Pharma sector. Reporting to Head of Research. From Sep 2011 to Jun 2013 with AMSEC (Asian Market Securities) as Research Analyst, tracking Pharma sector. Reporting to Head of Research. From May 2010 to Sep 2011 with Dalal & Broacha Stock Broking as Research Analyst, tracking Pharma sector. Reporting to Head of Research.

    • Rajat Srivastava

      From 6thSeptember 2024 onwards With Tata Asset Management Private Limited as Assistant Fund Manager & Research Analyst having responsibilities for Healthcare & Chemicals sector coverage, reporting to Chief Investment Officer - Equities. From October2022 to September 2024 With Incred Asset Management as AVP Investments having responsibilities for Automobile, Healthcare & Diversified sectors reporting to Fund Manager and CEO/CIO. From April 2022 to October 2022 With Kotak Investment Banking as Assistant Vice President-Corporate Advisory having responsibilities for Deal sourcing and reporting to Managing Director-Corporate Advisory Group. From November202 0 to April202 2 With Incred Asset Management as AVP Investments having responsibilities as Healthcare Analyst reporting to Fund Manager. From September20 19 to November 2020 With Emkay Global as Research Associate having responsibilities for coverage of healthcare sector stocks reporting to Lead Analyst. From June 2019 to September 2019 With Evalueserve (Client - Deutsche Securities) as Research Lead having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. From May 2016 to June20 19 With Motilal Oswal Financial Services as Assistant manager - Research having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. o

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59